600829.SS · 人民同泰
China A-shares · RS rating 64 · As of 2026-10-14
| Price | 9.25 CNY |
|---|---|
| 1-day change | -2.2% |
| RS rating (overall / 1M / 3M / 12M) | 64 / 36 / 85 / 82 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 28 / 24 / 30 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -8.5% |
| Distance from 52-week high | +47.8% |
| Market cap (USD) | $802.2M |